Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: A family study;Enfermedad celiaca (EC), colitis ulcerosa (CU) y colangitis esclerosante primaria (CEP) asociadas en el mismo paciente: Estudio familiar

Revista Espanola de Enfermedades Digestivas

Volumn 97, Issue 12, 2005, Pages 907-913

  Cadahia V ^a   Rodrigo, L ^a   Fuentes, D ^a   Riestra, S ^a   De Francisco, R ^a   Fernandez M ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Celiac disease (CD); Family study; Primary sclerosing cholangitis (PSC); Ulcerative colitis (UC)

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; URSODEOXYCHOLIC ACID;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CELIAC DISEASE; DIABETES CONTROL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILY STUDY; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIMARY SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS; ADULT; CHILD; FEMALE; GENETICS; INFANT; PEDIGREE; SCLEROSING CHOLANGITIS;

ADOLESCENT; ADULT; CELIAC DISEASE; CHILD; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; FEMALE; HUMANS; INFANT; MALE; PEDIGREE;

EID: 33745110714     PISSN: 11300108     EISSN: 11300108     Source Type: Journal    
DOI: 10.4321/S1130-01082005001200007     Document Type: Article

References (15)

1. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders in celiac disease. Endocrine Reviews 2002; 23: 464-83.
2. Zone JJ. Skin manifestations of celiac disease. Gastroenterology 2005; 128 (Supl. 1): S87-91.
3. Hakanen M, Luotola K, Salmi J, et al. Clinical and subclinical autoimmune thyroid disease in adult celiac disease. Dig Dis Sci 2001; 46: 2631-5.
4. Mac Faul GR, Chapman RW. Sclerosing cholangitis. Curr Op Gastroenterol 2004; 20: 275-80.
5. Smyth C, Kelleher D, Keeling PW. Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease and Whipple's disease. Clin Liver Dis 2002; 6: 1013-32.
6. Volta U, Rodrigo L, Granito A, et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002; 97: 2609-13.
7. Harbior A, Rawa T, Orlowska J, et al. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings. Eur J Gastroenterol Hepatol 2002; 14: 787-91.
8. Wurm P, Dixon AD, Rathbone BJ. Ulcerative colitis, primary cholangitis and coeliac disease: two cases and review of the literature. Eur J Gastroenterol Hepatol 2003; 15: 815-7.
9. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297-303.
10. Sategna C, Solerio E, Scaglione N, et al. Duration of gluten exposure in adult celiac disease does not correlate with the risk for autoimmune disorders. Gut 2002; 49: 502-5.
11. Cerruti F, Bruno G, Chiarelli F, et al. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes. Diabetes Care 2004; 27: 1294-8.
12. Biagi F, Pezzimenti D, Campanella J, et al. Gluten exposure and risk of autoimmune disorders. Gut 2002; 50: 140-1.
13. Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care 2005; 28: 806-9.
14. Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003; 124: 889-93.
15. Rodrigo L, Riestra S, Fuentes D, González S, López- Vázquez A, López-Larrea C. Diversas formas clínicas de presentación de la enfermedad celíaca dentro de la misma familia. Rev Esp Enferm Dig 2004; 96: 612-9.